Background: In 2002, the Committee for Standardized Reporting Practices in Vascular Surgery of the Society for Vascular Surgery/American Association for Vascular Surgery proposed an anatomic severity grade score to categorize and to define anatomic factors as they relate to infrarenal abdominal aorta aneurysms (AAAs).
1 The original purpose of this score was to quantitatively assess anatomic complexity of the aorta before undertaking a repair. Our group previously reported that aortic anatomic complexity is a marker of atherosclerotic risk and resource utilization at the time of repair. 2, 3 However, it remains unclear whether individual components to this scoredspecifically the aortic and iliac calcium burdend independently contribute to midterm survival after AAA repair. The purpose of this study was to analyze and to validate an aortic and iliac artery calcium scoring system that can predict midterm mortality after AAA repair. These data have direct implications for the population management-based treatment of aortic aneurysmal disease.
Methods:
Patients with complete 5-year records who underwent open and endovascular infrarenal AAA repairs between July 2007 and May 2012 at the University of Rochester Medical Center were retrospectively identified using Current Procedural Terminology (American Medical Association, Chicago, Ill) codes 34800, 34802, 34803, 34804, and 34805. To avoid potential interference from perioperative mortality, those who died within 30 days of surgery were not included. Degree of vessel calcification was obtained from preoperative computed tomography scans no more than 6 months before surgery, calculated manually using three-dimensional reconstruction software (Philips Intellispace Portal; Koninklijke Philips Electronic NV, Andover, Mass) by two blinded reviewers. Calcium score (CS) was defined using the anatomic severity grade scoring system for its basis. 7 (5-9) 7 (6-10) 8 (6-12) <.001
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242 (98) 252 (104) was developed to determine an appropriate CS threshold for analysis. Kaplan-Meier survival curves of the groups defined by this threshold were compared with log-rank and Wilcoxon signed rank tests, with statistical significance of P < .05. Patients who survived and those who did not were compared in regard to the following variables: CS, sex, race, age at time of surgery, hypertension, hyperlipidemia, diabetes, coronary artery disease, chronic obstructive pulmonary disease (COPD), chronic kidney disease, end-stage renal disease (ESRD), presence of neoplasms, and specific pharmacologic therapies (beta blockers, angiotensin-converting enzyme inhibitors, aspirin, clopidogrel, and statins). The Pearson c 2 test was used to compare categorical variables, and the Student t-test was used to compare continuous variables between the two groups. Each variable with a P value < .1 between the groups was then placed into a Cox proportional hazards model, with statistical significance of P < .05. All statistical analysis was performed using SAS software version 9.4 (SAS Institute, Cary, NC).
Results: During our study period, 356 patients underwent AAA repair and had complete calcium and survival data who did not die within 30 days of AAA repair. Of 356 patients, 93 (26%) died within 5 years of AAA repair; 47 (13%) had CS of 0, with 7 (15%) deaths; 98 (28%) had CS of 1, with 21 (21%) deaths; 86 (24%) had CS of 2, with 21 (24%) deaths; 83 (23%) had CS of 3, with 29 (35%) deaths; 35 (10%) had CS of 4, with 14 (40%) deaths; and 6 (2%) had CS of 5, with 1 (17%) death.
The developed receiver operating characteristic curve from these data demonstrated an appropriate threshold of CS of 3, with area under the curve of 0.61. There were 231 of 356 (65%) who had a CS <3, whereas 125 of 356 (35%) had a CS $3. These two populations were similar, except those with CS $3 had higher rates of COPD (31.2% vs 16%; P ¼ .0008) and female gender (25.6% vs 16%; P ¼ .0290) . Fig demonstrates the 5 -year Kaplan-Meier curves of these two groups, with a statistically significant greater 5-year mortality probability in patients with a CS $3 (35.2% vs 21.2%; log-rank, P ¼ .0030; Wilcoxon, P ¼ .0032).
In comparing the 5-year mortality and survivor groups, chronic kidney disease (15.1% vs 6.8%; P ¼ .0173), ESRD (3.2% vs 0%; P ¼ .0034), COPD (30.1% vs 18.2%; P ¼ .0164), beta blocker use (87.1% vs 78.7%; P ¼ .0769), age (average of 77 vs 71 years; P < .0001), and CS $3 (47.3% vs 30.8%; P ¼ .0041) had P < .1 and were appropriate to be used for a Cox proportional hazards analysis. Table demonstrates the results of this analysis. CS of $3 was associated with a statistically significant hazard ratio (HR) of 1.579 (95% confidence interval [CI], 1.038-2.402; P ¼ .0328). ESRD (HR, 9.013; 95% CI, 2.925-27.776; P ¼ .0001), COPD (HR, 1.804; 95% CI, 1.138-2.860; P ¼ .0121), and age (HR, 1.065; 95% CI, 1.037-1.093; P < .0001) were also associated with HR >1.
Conclusions: The calcium scoring system presented herein is the first known system that validates a calcium scoring scheme that can signify increased midterm mortality after AAA repair. The degree of vessel calcification has been known to signify an overall burden of vascular disease, which has been examined in other specialties, including cardiology, and linked to mortality. In 2015, Shaw et al published a cohort study that demonstrated a coronary calcification score accurately predicting 15-year all-cause mortality in 9715 asymptomatic patients. Those with no score experienced a 3% mortality rate, whereas those with a score of 1000 or more experienced a 28% mortality rate. 4 Our system potentially can be another measure to risk stratify patients undergoing AAA repair and serve as a means to predict midterm mortality probability. This study serves as a stepping stone in using this validated scoring system as a guide in decision-making in surgical intervention of AAAs at both the patient and population levels. These data have the potential to assist value-based decisions in a variety of vascular disease states.
Limitations to this study include that it was retrospective in nature, covered only a particular population of AAA patients, did not include nonrepaired cases, and lacked data points at the extremes of CS (fewer patients had a CS of 0 or 5) and that the means of calcium measurement were done manually, as automated software to do this does not yet exist. Future data will be needed to further validate this scoring system in predicting midterm mortality in patients undergoing AAA repair and to further develop the system in guiding decision-making in surgical repair of AAAs. 
